Profile
Mr. Michael P.
Short is Vice President-Business Strategy & Development at Embera NeuroTherapeutics, Inc. He is on the Board of Directors at 4C Consulting Ltd.
Mr. Short was previously employed as General Manager by PathoGenesis Corp, a Principal by Baxter International, Inc., Chief Executive Officer by GlycoForm Ltd., Chief Executive Officer by RioTech Pharmaceuticals Ltd., Chief Executive Officer by Iridian Technologies, Inc., and President, VP-Business Strategy & Development by BaroFold, Inc.
He received his MBA from the University of Aston.
Former positions of Michael Peter Short
| Companies | Position | End |
|---|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Corporate Officer/Principal | 01/01/2000 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1996 |
4C Consulting Ltd.
4C Consulting Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Director/Board Member | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Executive Officer | - |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes protein therapeutics | President | - |
Training of Michael Peter Short
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes protein therapeutics | Health Technology |
Iridian Technologies, Inc.
Iridian Technologies, Inc. Information Technology ServicesTechnology Services Develops and commercializes authentication recognition software solutions | Technology Services |
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic drugs for hepatitis C virus | Health Technology |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Aston
University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4C Consulting Ltd.
4C Consulting Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
- Stock Market
- Insiders
- Michael Peter Short
















